Mirabegron: a safety review

Beta3-adrenoceptor agonists for the treatment of overactive bladder

(2015) P. Tyagi et al.   DRUGS OF THE FUTURE

Emerging drugs for treatment of urinary incontinence

(2010) Monika Vij et al.   EXPERT OPINION ON EMERGING DRUGS

Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage

(2009) Miriam G. Cisternas et al.   CURRENT MEDICAL RESEARCH AND OPINION

Abstracts of the FIGON Dutch Medicine Days in Lunteren on 6-8 October 2008

(2009)   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Investigations into the presence of functional ß1, ß2 and ß3-adrenoceptors in urothelium and detrusor of human bladder

(2009) Pradeep Tyagi et al.   International Braz J Urol

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

(2008) Christopher R. Chapple et al.   EUROPEAN UROLOGY

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-controlled, Double-blind, Crossover Study With Tolterodine and Darifenacin in Healthy Participants ≥50 Years

(2008) Brian Olshansky et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS